本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inhibikase Therapeutics, Inc.

1.70
-0.0700-3.95%
盘后1.700.00000.00%16:10 EDT
成交量:5.77万
成交额:9.91万
市值:1.26亿
市盈率:-2.07
高:1.83
开:1.80
低:1.70
收:1.77
数据加载中...
2024/10/25

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/22

重要事件披露

Form 8-K - Current report
2024/10/17

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/17

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

重要事件披露

Form 8-K - Current report
2024/10/10

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/09

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/06/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]